18:44 , Aug 31, 2018 |  BC Week In Review  |  Financial News

China Biologic spurns acquisition proposal, seeks $590M raise

Plasma products company China Biologic Products Holdings Inc. (NASDAQ:CBPO) said it turned down an acquisition proposal made on Aug. 17, and said it is raising $590 million in a private placement. The Aug. 17 proposal...
21:07 , Aug 20, 2018 |  BC Extra  |  Company News

Consortium including Gao, GL Capital bid to take China Biologic private

A consortium comprising former executive David Gao, GL Capital Group, Bank of China Group Investment Ltd. and CDH Investments proposed on Friday to take plasma products company China Biologic Products Holdings Inc. (NASDAQ:CBPO) private for...
08:00 , Mar 7, 2011 |  BC Week In Review  |  Company News

BMP Sunstone, sanofi-aventis deal

sanofi-aventis completed its previously announced acquisition of Chinese consumer healthcare company BMP Sunstone for $10 per share in cash, or about $520.6 million. Stephens Inc. advised BMP Sunstone, while Morgan Stanley advised sanofi-aventis (see BioCentury,...
07:00 , Nov 1, 2010 |  BC Week In Review  |  Company News

BMP Sunstone, sanofi-aventis deal

sanofi-aventis will acquire Chinese consumer healthcare company BMP Sunstone for $10 per share in cash, or about $520.6 million. The price is a 31% premium to BMP's close of $7.66 on Oct. 27, the day...
00:55 , Oct 29, 2010 |  BC Extra  |  Financial News

Lovenox sales decline

sanofi-aventis Group (Euronext:SAN; NYSE:SNY) said third quarter sales of Lovenox enoxaparin fell 26% to EUR 537 million ($732 million) compared to 3Q09 due to generic competition for the anticoagulant. Last week, Novartis AG (NYSE:NVS; SIX:NOVN)...
07:00 , May 19, 2008 |  BC Week In Review  |  Clinical News

Enablex: CTA accepted

In 1H09, BMP Sunstone Corp. (NASDAQ:BJGP, Plymouth Meeting, Pa.) plans to start a Chinese trial of Enablex darifenacin. The company licensed exclusive rights from Novartis to market and distribute Enablex in China (see BioCentury, Dec....